Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Alzheimer Disease

New drug could reduce risk of early-onset Alzheimer’s disease

The results boost hopes similar treatments being developed to target more common forms of Alzheimer's - that appear when people reach their sixties, seventies and eighties - might also be effective.

The Independent UK

Changes to speech and language can help detect Alzheimer’s early – here are five things to look out for

Ten million people are diagnosed with dementia worldwide each year – that’s more than ever. According to the Alzheimer’s Society approximately one million people in the UK are currently living with the disease. Studies predict this figure will rise to 1.6 million people by 2050.

The Conversation

Alzheimer’s research centers face Trump-imposed $65m funding delay across the US

Researchers report difficulties retaining staff as White House cost-cutting stresses US medical research system

The Guardian - US

From analysis to the latest developments in health,
read the most diverse news in one place.

Man nearly guaranteed to get early Alzheimer's is still disease-free in his 70s — how?

A man who should have developed early-onset Alzheimer's disease due to a genetic mutation is still symptom-free in his 70s. Scientists are trying to understand why.

LiveScience

Meet the 24-year-old helping Lilly test a preventive Alzheimer’s drug

Children who inherit genetic mutations from parents with early-onset Alzheimer’s typically show signs of dementia at the same age their parents did.

Fortune

It's not just forgetfulness: 8 early warning signs of dementia

Nightmares and changes in vision can both be early warning signs of dementia.

Fortune

Alzheimer’s may not be from amyloids

Recent studies implicate the immune system and a herpes virus as potential contributors to development of disease

Salon

Read news from The Economist, FT, and more,
with one subscription

Jobs That Save Lives? People In Certain Professions May Be At Reduced Risk Of Alzheimer's Death

Professions requiring constant navigation, such as taxi and ambulance drivers, might be at an advantage as a recent study found these workers have a reduced risk of death from Alzheimer's disease.

Medical Daily

New study will use phone apps to explore link between sleep and Alzheimer's risk

Cambridge University and UCL will collaborate with a tech company to explore how sleep tracking data can help detect Alzheimer's disease

Tom’s Guide

These surprising professions have the lowest rate of Alzheimer’s disease deaths

Alzheimer’s disease is a form of dementia and it is one of the leading causes of death in the United States

The Independent UK

Does menopause hormone therapy increase or decrease your risk of dementia? Here’s the science

By 2050, around 135 million people worldwide will be living with dementia. The most common cause of dementia is Alzheimer’s disease. Women are more likely than men to develop Alzheimer’s disease, even after accounting for women living longer.

The Conversation

AI supercharged the sciences in 2024, revealing a major breakthrough in Alzheimer's diagnosis

A surge of AI-powered breakthroughs reminds us of the good that artificial intelligence can do, when placed in the right hands.

Laptop

How one health concern could predict Alzheimer’s disease decades before first symptoms occur

Alzheimer’s disease affects millions of Americans and is one of the top 10 causes of death in the U.S.

The Independent UK

Cannabinoid Drug For Agitation In Alzheimer's Yields Cognitive Improvements In Clinical Trial

IGC Pharma, Inc.(NYSE:IGC) reported additional interim data from its ongoing Phase 2 clinical trial evaluating IGC-AD1 for agitation in dementia associated with Alzheimer's disease. IGC-AD1 targets neuro-inflammation and CB1 receptor dysfunction,. The investigational drug contains THC as one of two active pharmaceutical agents.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

Vulnerability to financial scams in aging adults could be an early indicator of Alzheimer’s disease, new research shows

A brain region affected very early in Alzheimer’s disease may explain why some aging people are at greater risk of financial exploitation. That is the key finding of our new study, published in the journal Cerebral Cortex.

Dynamite News

Study finds how Alzheimer's disease may damage brain in two phases

Alzheimer's disease may cause brain damage in two stages, according to new research supported by the National Institutes of Health (NIH) that uses sophisticated brain mapping methods. Read further on Dynamite News:

Evening Standard

Blood test could ‘reliably rule out’ Alzheimer’s, trial finds

There are hopes it will offer reassurance to patients with cognitive decline and help them avoid unnecessary further testing, researchers said.

The Conversation

Alzheimer’s drug approved in the UK, but it won’t be available on the NHS – here’s why

The UK’s drugs regulator – the MHRA – has approved the Alzheimer’s drug donanemab, but it won’t be available on the NHS.

Get all your
news in one place.

100’s of premium titles.
One news app.

Kiplinger

Fell for a Financial Scam? Might Be Time to Test for Alzheimer's

Falling for financial scams may be an early indicator of Alzheimer's among older adults.

Inverse

Ozempic Outperformed 7 Diabetes Medications in Reducing the Risk for Alzheimer’s Disease

Semaglutide outperformed 7 diabetes medications in reducing risk of Alzheimer's disease, according to a study of over 1 million patients with type 2 diabetes.

Evening Standard

Alzheimer's 'wonder drug' Donanemab blocked for use on NHS over cost concerns

Campaigners say decision is ‘frustrating setback’ for people living with disease

The Independent UK

Donanemab: What is the new Alzheimer’s drug rejected for use on the NHS

Donanemab and another new drug for Alzheimer’s called Lecanemab have been billed as a huge step forward in research

Evening Standard

Alzheimer’s drug rejected for widespread use by NHS spending watchdog

Donanemab is a so-called disease-modifying treatment.

Evening Standard

Donanemab – what we know about the latest Alzheimer’s drug

The drug is one of the new ‘disease modifying’ treatments for Alzheimer’s disease.

The Conversation

Why light pollution may be linked to greater risk of Alzheimer’s disease

Light pollution is a growing issue. Over the past 25 years, artificial lighting has surged by 49% worldwide. For perspective, the brightness of the night sky has risen by almost 10% per year over the last 12 years. Around 80% of the global population is now affected by light pollution.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

University of Michigan

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.